Adherence to the CDK 4/6 inhibitor palbociclib and omission of dose management supported by pharmacometric modelling as part of the OpTAT study
C Bandiera, I Locatelli, P Courlet, E Cardoso, K Zaman… - Cancers, 2023 - mdpi.com
Simple Summary Medication adherence to CDK4/6 inhibitors such as palbociclib,
prescribed as a cyclic oral anticancer therapy in women diagnosed with advanced breast …
prescribed as a cyclic oral anticancer therapy in women diagnosed with advanced breast …
A novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191
XY Zheng, Y Lv, LY Xu, DM Zhou, L Yu, ZY Zhao - Hereditas, 2024 - Springer
Background The therapeutic potential of oncolytic measles virotherapy has been
demonstrated across various malignancies. However, the effectiveness against human …
demonstrated across various malignancies. However, the effectiveness against human …
Mapping the experiences of people with advanced cancer across multiple cancer types—a scoping review
Background Through the introduction of tumor agnostic therapies, people with metastatic
cancer and their treating physicians are facing new treatment choices that have differing …
cancer and their treating physicians are facing new treatment choices that have differing …
[PDF][PDF] Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women With HR+/HER2-Breast Cancer
Background: Adherence to oral anticancer therapies among breast cancer patients is an
often-overlooked issue. Lack of patients' compliance can be caused by several factors, and …
often-overlooked issue. Lack of patients' compliance can be caused by several factors, and …
[PDF][PDF] Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study …
C Bandiera, I Locatelli, P Courlet, E Cardoso… - 2023 - access.archive-ouverte.unige.ch
The cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) palbociclib is administered orally and
cyclically, causing medication adherence challenges. We evaluated components of …
cyclically, causing medication adherence challenges. We evaluated components of …